Identifying a highly specific autoantibody response targeting the NC7-Col4 region in DPP4i-BP suggests the potential use of this epitope as a biomarker for early detection or risk stratification in patients with diabetes treated with DPP4 inhibitors. The gene discussed is DPP4; the disease is diabetes mellitus.